fda approved semaglutide weight loss New Medication Wegovy™ by the US FDA approves weight loss

Efficacy and Side Effects Both Semaglutide and Tirzepatide have demonstrated significant weight loss effects in clinical trials, often surpassing those seen with other weight loss medications

Regular follow-ups ensure that any necessary adjustments to the treatment plan are made, promoting long-term success in weight management

The rational approach is to use the assessment framework outlined earlier, consult with your pharmacy, and make a decision based on evidence rather than emotion

Heres how this innovative treatment aligns with our mission and practice

The team randomly assigned half of the patients a weekly semaglutide shot and the other half a placebo for six months